Hsbc Holdings PLC Decreases Stake in Novanta Inc. $NOVT

Hsbc Holdings PLC lessened its position in shares of Novanta Inc. (NASDAQ:NOVT) by 39.5% in the 1st quarter, HoldingsChannel reports. The fund owned 112,081 shares of the technology company’s stock after selling 73,074 shares during the period. Hsbc Holdings PLC’s holdings in Novanta were worth $13,077,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the company. Danske Bank A S acquired a new stake in shares of Novanta in the 3rd quarter valued at $40,000. Allworth Financial LP lifted its position in shares of Novanta by 978.4% during the 4th quarter. Allworth Financial LP now owns 399 shares of the technology company’s stock worth $47,000 after purchasing an additional 362 shares during the last quarter. EverSource Wealth Advisors LLC grew its stake in shares of Novanta by 120.1% during the fourth quarter. EverSource Wealth Advisors LLC now owns 427 shares of the technology company’s stock worth $51,000 after purchasing an additional 233 shares in the last quarter. ANTIPODES PARTNERS Ltd purchased a new position in Novanta in the fourth quarter valued at $53,000. Finally, Farther Finance Advisors LLC increased its holdings in Novanta by 1,291.4% in the fourth quarter. Farther Finance Advisors LLC now owns 487 shares of the technology company’s stock valued at $58,000 after buying an additional 452 shares during the last quarter. 98.35% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have issued reports on NOVT shares. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Novanta in a report on Wednesday, July 15th. Wall Street Zen upgraded Novanta from a “hold” rating to a “buy” rating in a report on Saturday, June 27th. Finally, Robert W. Baird set a $180.00 target price on Novanta in a research report on Tuesday, June 9th. One equities research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Novanta currently has an average rating of “Hold” and an average target price of $180.00.

Novanta Stock Down 0.4%

Shares of NASDAQ NOVT opened at $145.25 on Thursday. The stock has a market cap of $5.48 billion, a PE ratio of 105.25 and a beta of 1.67. The company has a quick ratio of 2.69, a current ratio of 3.56 and a debt-to-equity ratio of 0.15. Novanta Inc. has a 52-week low of $98.27 and a 52-week high of $171.85. The business has a 50-day moving average price of $156.11 and a 200 day moving average price of $139.87.

Novanta (NASDAQ:NOVT) last released its quarterly earnings results on Monday, May 11th. The technology company reported $0.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.78 by $0.03. The firm had revenue of $257.71 million for the quarter, compared to the consensus estimate of $253.40 million. Novanta had a return on equity of 12.06% and a net margin of 5.35%.The firm’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.74 EPS. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. Equities research analysts forecast that Novanta Inc. will post 3.59 earnings per share for the current year.

Insider Buying and Selling at Novanta

In other news, CEO Matthijs Glastra sold 6,500 shares of the firm’s stock in a transaction that occurred on Thursday, July 2nd. The shares were sold at an average price of $161.13, for a total transaction of $1,047,345.00. Following the transaction, the chief executive officer directly owned 29,761 shares in the company, valued at approximately $4,795,389.93. This trade represents a 17.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.20% of the company’s stock.

About Novanta

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.